However, Wang et al. [37] reported that 53.5% of colon cancer patients show YAP overexpression, and this overexpression was found to be associated with lymph node metastasis, TNM staging, and a short overall survival rate. Here, YAP1 is linked to metastatic malignant neoplasm in the lymph nodes.